TNAX Biopharma
Tokyo
About TNAX Biopharma
TNAX Biopharma is a developer of pharmaceuticals drugs intended to improve the quality of life of patients.The company provides novel antibody therapeutics for unmet medical needs of patients with intractable diseases, thus providing patients therapeutics around the world through drug discovery innovation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10M+
- Total funding: $9.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2019)
- Website: tnaxbio.com
- Phone: +81-70-3549-3901
Industries & Categories
Biotechnology, Life Science, Medical, Nursing and Residential Care, Therapeutics
Canonical: https://fsome.com/organization/tnax-biopharma-2295830 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.